Pharmacological Potential of Hippophae rhamnoides L. Nano-Emulsion for Management of Polycystic Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies
ACS Omega · 12.09.2023 · 8 (36) · 32977-32989
DOI: 10.1021/acsomega.3c04720 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 28.08.2023. Verfasst von Liaqat Hussain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38040, Pakistan. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
The most common female endocrinopathy, polycystic ovarian syndrome (PCOS), generally affects women of childbearing age. Hippophae rhamnoides L. has been traditionally used to improve menstrual cyclicity. Gas chromatography by flame ionization detection analysis showed that it contained various phytoconstituents such as omega-3 fatty acid, phytosterols, palmitic acid, oleic acid, and linoleic acid. H. rhamnoides L. (HR) nano-emulsion was also formulated. HR and its encapsulated nano-emulsion (HRNE) were evaluated for the treatment of PCOS. Thirty-five healthy female adult albino rats were acquired and divided into seven groups (n = 5). Letrozole (1 mg/kg) was used for 5 weeks to induce the disease. To confirm disease (PCOS) induction, the animals were weighed weekly and their vaginal smears were analyzed daily under a microscope. After PCOS induction, animals were treated with metformin, HR, and HRNE with two different doses (0.5/kg and 1 g/kg, p.o.) for 5 weeks. At the end of the treatment, animals were euthanized, and blood was collected for hormonal assessment, lipid profiling, and liver functioning test assessment. Both the ovaries were preserved for histopathology and liver for the purpose of assessment of antioxidant potential. The results revealed that HR and HRNE at both doses improved the hormonal imbalance; follicle-stimulating hormone, estrogen, and progesterone levels are increased, while luteinizing hormone surge and testosterone level are controlled. Insulin sensitivity is improved. Ovarian histopathology showed that normal ovarian echotexture is restored with corpus luteum and mature and developing follicles. HR and HRNE also improved the lipid profile and decreased lipid peroxidation (MDA) with improved antioxidant markers (SOD, CAT, and GSH). Results were statistically analyzed by one-way analysis of variance and were considered significant only if p < 0.05. In conclusion, it can be postulated that H. rhamnoides L. proved effective in the management of PCOS and its nano-emulsion effects were statistically more significant, which might be due to better bioavailability.
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38040, Pakistan.
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38040, Pakistan.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Post Box 2455, Riyadh 11451, Saudi Arabia.
- College of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, China.
- College of Pharmacy, Freie Universitaet Berlin, Berlin 14195, Germany.
ORCID-Profile: Liaqat Hussain, Ghulam Abbas
Förderung
- King Saud University
Zitieren
APA
Hussain, L., Rana, S., Abbas, G., Alshammari, A., Alasmari, A. F., Alharbi, M., Zahid, M. T., & Irfan, M. (2023). Pharmacological Potential of Hippophae rhamnoides L. Nano-Emulsion for Management of Polycystic Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies. ACS Omega, 8(36), 32977-32989. https://doi.org/10.1021/acsomega.3c04720
Vancouver
Hussain L, Rana S, Abbas G, Alshammari A, Alasmari AF, Alharbi M, et al. Pharmacological Potential of Hippophae rhamnoides L. Nano-Emulsion for Management of Polycystic Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies. ACS Omega. 2023;8(36):32977-32989. doi:10.1021/acsomega.3c04720
BibTeX
@article{Hussain2023,
author = {Hussain, Liaqat and Rana, Saba and Abbas, Ghulam and Alshammari, Abdulrahman and Alasmari, Abdullah F and Alharbi, Metab and Zahid, Muhammad Toseef and Irfan, Muhammad},
title = {Pharmacological Potential of Hippophae rhamnoides L. Nano-Emulsion for Management of Polycystic Ovarian Syndrome in Animals’ Model: In Vitro and In Vivo Studies},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {36},
pages = {32977--32989},
doi = {10.1021/acsomega.3c04720}
}
EUVIMED